Patents
Patents for C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium (663)
05/2013
05/01/2013CN101321750B Multimeric magnetic resonance contrast agents
12/2012
12/20/2012US20120322744 Poly-pegylated protease inhibitors
12/04/2012US8324187 Stabilized formulations of phosphatidylserine
04/2012
04/11/2012CN102407159A 使用铬基催化剂的乙烯三聚 Use of chromium-based ethylene trimerization catalyst
02/2012
02/21/2012CA2540170C Stabilized formulations of phosphatidylserine
12/2011
12/13/2011US8076347 (-)-(2S,4S)-1-(2-hydroxymethyl-1,3-dioxolan-4-yl)cytosine (OddC); "L"-nucleoside that exhibits anti-tumor activity; anticarcinogenic agent for non-small cell lung cancer, colon, breast, prostate, ovarian, CNS, renal, and lymphoma cancer, leukemia, melanoma
11/2011
11/22/2011CA2519172C Phosphoric ester demulsifier composition
11/01/2011CA2481261C Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
10/2011
10/18/2011CA2434927C Pharmaceutical compositions with antibiotic activity
09/2011
09/13/2011US8017776 Methods for synthesis of acyloxyalkyl compounds
08/2011
08/24/2011CN102160651A Stabilized formulations of phosphatidylserine
07/2011
07/14/2011US20110172140 Poly-Pegylated Protease Inhibitors
01/2011
01/25/2011CA2420764C Compositions comprising dimeric or oligomeric ferrocenes
01/25/2011CA2368849C Process for preparing amine platinum complexes
12/2010
12/15/2010CN1916009B Process for preparing amine platinum complexes
12/01/2010EP1791851B1 Process for preparation of alkyl phosphinates
11/2010
11/09/2010CA2397583C New aminopropylphosphinic acids
10/2010
10/05/2010US7807658 Administering an optionally substituted 3-aminopropylphosphinic acid (3-amino-2-fluoropropyl)phosphinic acid, 3-amino-2-oxopropyl)phosphinic acid); irritable bowel syndrome
05/2010
05/12/2010CN1762957B 2,3-dihydro-1-indene compound and preparation method thereof
03/2010
03/31/2010EP0559730B1 Polymeric materials
03/23/2010CA2393617C Vitamin d precursors, method and intermediates
02/2010
02/18/2010US20100041882 Methods for synthesis of acyloxyalkyl compounds
02/16/2010US7662987 Methods for synthesis of acyloxyalkyl compounds
02/02/2010CA2294809C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same
01/2010
01/19/2010US7649015 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing
12/2009
12/30/2009CN100575355C Process for preparation of alkyl phosphinates
12/29/2009CA2300243C Process for preparing n-[5-(diphenylphosphinoylmethyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl]-n-methylmethanesulphonamide
09/2009
09/15/2009CA2380841C A process for the preparation of 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid and of the trihydrated monosodium salt thereof
07/2009
07/07/2009US7557234 Production of alkyl dialkoxyalkylphosphinates by reaction of a hypophosphite salt with a trialkylorthoformate in the presence of methanesulfonic acid; suitable for large-scale production
06/2009
06/23/2009US7550427 Poly-pegylated protease inhibitors
03/2009
03/24/2009US7507820 Diazaphosphacycles
03/24/2009US7507783 lithographic compositions of a silane-functional acrylate type polymer for use as middle or protective layers during circuit manufacturing; or may contain a polyhedral oligomeric silsesquioxane-containing polymer and/or a polyhedral oligomeric silsesquioxane; can be applied as very thin film
02/2009
02/11/2009CN100460412C Process for preparing amine platinum complexes
01/2009
01/14/2009CN100451024C Metallocene compound, indene compound and application thereof
12/2008
12/25/2008US20080319231 Production of alkyl dialkoxyalkylphosphinates by reaction of a hypophosphite salt with a trialkylorthoformate in the presence of methanesulfonic acid; suitable for large-scale production
12/10/2008CN101321750A Multimeric magnetic resonance contrast agents
12/09/2008US7462608 Non nucleoside reverse transcriptase inhibitors
09/2008
09/09/2008CA2287881C Vitamin d3 analogs with bis c-20 side chains
08/2008
08/13/2008CN101239090A Pharmaceutical compositions having appetite suppressant activity
08/13/2008CN101239089A Pharmaceutical compositions having appetite suppressant activity
07/2008
07/17/2008US20080171758 Compounds and methods for the treatment of cancer
06/2008
06/19/2008US20080146836 New Aminopropylphosphinic acids
06/10/2008CA2297838C Method of manufacturing phosphine compound
04/2008
04/29/2008CA2363317C Novel process for preparing alendronic acid
04/09/2008CN101156861A Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds
04/02/2008CN100378118C Pharmaceutical compositions having appetite suppressant activity
02/2008
02/20/2008CN101125864A Heteroaromatic inhibitor for fructose-1,6-bisphosphatase
12/2007
12/04/2007US7303755 Use of sodium and potassium salts of citric, phosphoric, carbonic and tartaric acid and arginine and lysine as stabilizer of the antibiotic Fosfomycin Tromethamine
11/2007
11/28/2007CN100351246C Process for selective derivatization of taxanes
11/21/2007CN101074242A Cells accumulation for sphosphonate analogs of HIV protease inhibitor compound and the same compound
11/21/2007CN100349904C Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase
11/14/2007EP1509537B9 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/13/2007US7294733 Method for preparing formylphosphonic acid
10/2007
10/30/2007US7288665 Process for selective derivatization of taxanes
09/2007
09/26/2007CN101041669A Non nucleoside reverse transcriptase inhibitors
08/2007
08/28/2007US7262213 Administering (-)-(2S,4S)-1-(2-Hydroxymethyl-1,3-dioxolan-4-yl)cytosine (also referred to as (-)-OddC) for therapy of cancer such as non-small cell lung cancer, colon cancer, breast cancer, prostate cancer, ovarian cancer, leukemia, CNS cancer, melanoma, renal cancer, and lymphoma cancer
08/16/2007US20070190523 Method and compositions for identifying anti-hiv therapeutic compounds
08/15/2007CN101018794A Process for preparation of alkyl phosphinates
07/2007
07/18/2007EP1509537B1 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
07/18/2007EP1313748B1 Regenration of particle filters with compositions comprising dimeric or oligomeric ferrocenes
07/12/2007US20070160659 Stabilized formulations of phosphatidylserine
07/10/2007CA2283564C Pharmaceutical compositions having appetite suppressant activity
06/2007
06/20/2007CN1982459A Method of preparing mammal cell kinetin synthesis inhibitoroy factor
06/13/2007EP1795528A1 Process for selective derivatization of taxanes
06/06/2007EP1792908A1 Compositions comprising dimeric or oligomeric ferrocenes
06/06/2007EP1791851A1 Process for preparation of alkyl phosphinates
06/06/2007CN1974563A Process for selective derivatization of taxanes
05/2007
05/15/2007US7217779 prepared by reacting one or more alkylphenol-formaldehyde resin alkoxylates or one or more polyalkylene glycols with one or more phosphorous compounds selected from phosphorous oxychloride, phosphorous pentoxide and phosphoric acid
05/02/2007CN1313472C Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such
02/2007
02/28/2007CN1919200A Method for inhibiting bone resorption
02/22/2007US20070041959 polymer conjugated polypeptide contains polyoxyethylene glycol binding to a Kunitz domain which specifically binds and/or inhibits a protease; modified protease inhibitors; increase the molecular weight of the compound
02/21/2007CN1916009A Process for preparing amine platinum complexes
02/20/2007CA2169561C Process for producing n-amino-1-hydroxy-alkyl-idene-1,1-bisphosphonic acids
02/01/2007US20070027115 Triazole derivatives useful in therapy
01/2007
01/25/2007WO2004046155A3 Predicting outcome of hyperbaric oxygen therapy treatment with nitric oxide bioavailability
01/25/2007US20070021393 New use of GabaB receptor agonists
01/25/2007US20070020252 Modified protease inhibitors
01/24/2007CN1900087A Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase
01/23/2007US7166611 Plant extract comprising steroidal glycosides from the genus Trichocaulon or Hoodia produced by solvent extraction
01/23/2007CA2182987C Novel phosphoric acid-amino acid complex salt and additive composition containing the salt and used in feed for ruminant mammals
01/17/2007CN1897919A Stabilized formulations of phosphatidylserine
01/11/2007US20070010489 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing
11/2006
11/30/2006WO2004076465A8 Silyl acrylate and poss compositions used in microlithographic processes
11/02/2006EP1716923A1 Oxidation catalyst for making glyphosate
11/02/2006EP0973534B1 Plant extracts having appetite suppressant activity
10/2006
10/18/2006EP1711617A1 Method and compositions for identifying anti-hiv therapeutics compounds
10/18/2006CN1847253A Process for preparing amine platinum complexes
10/04/2006EP0956284B1 Process for selective derivatization of taxanes
09/2006
09/28/2006WO2005064008A9 Method and compositions for identifying anti-hiv therapeutic compounds
09/21/2006US20060211881 Method for preparing formylphosphonic acid
09/14/2006US20060205931 Pharmaceutical compositions having appetite suppressant activity
09/06/2006CN1827108A Use of cytosine derivative for preparing drug for treating cancer
08/2006
08/15/2006US7091376 Contacting formaldehyde, phosphorous acid and an amine to produce a phosphonomethylation reaction product; contacting with water and an oxidizing gas in the presence of a catalyst, contactingformylphosphonic acid derivative with glycine, reducing to produce N-(phosphonomethyl) glycine
08/02/2006EP1107974B1 Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
08/02/2006EP1073637B1 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases
07/2006
07/19/2006CN1803810A Antiviral agents and preparing method thereof
06/2006
06/21/2006EP1671960A2 Process for selective derivatization of taxanes
06/15/2006US20060128692 Non nucleoside reverse transcriptase inhibitors
06/15/2006US20060128572 Phosphoric esters of polyisobutene-substituted aromatic hydroxy compounds
06/07/2006EP1663281A2 Poly-pegylated protease inhibitors
1 2 3 4 5 6 7